| Bioactivity | EGFR-IN-135 (compound 3d) is a EGFR inhibitor with the IC50 of 0.086 µM. EGFR-IN-135 inhibitor cell growth and arrests the cell cycle at the S phase of reast cancer cell lines[1]. |
| Formula | C12H14N4OS2 |
| Molar Mass | 294.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mohammed ER, et al. Synthesis of S-alkylated oxadiazole bearing imidazo[2,1-b]thiazole derivatives targeting breast cancer: In vitro cytotoxic evaluation and in vivo radioactive tracing studies. Bioorg Chem. Published online November 2, 2024. |